• 

  August 31, 2026

  Linton Lifesciences and ClonalStem Explore Engineered Environments for Vascular Cells

  Ricky Solorzano

• 

  July 19, 2026

  Vivodyne Is Trying to Industrialize Human Tissue Testing

  Ricky Solorzano

• 

  April 29, 2026

  OHSU Secures $9.2M NIH Grant to Advance Bone Cancer Organs-on-Chips Research

  Ricky Solorzano

• 

  April 27, 2026

  The Organ-on-Chip, Microphysiological Systems Landscape, NAMs: A Business Overview

  Ricky Solorzano

• 

  April 24, 2026

  Linton Lifesciences Launches Biofabricated NAMs: Rebuilding the Missing Layer Between Biology and Decision-Making

  Ricky Solorzano

• 

  April 6, 2026

  NAMs, New Approach Methodologies for Drug Discovery: What It Means for the Future of Alternatives to Animal Testing and Biofabrication

  Ricky Solorzano

• 

  December 15, 2025

  Revalia Bio Secures ~$30M Government Contract to Build the Future of Human-First Drug Development

  Ricky Solorzano

• 

  October 10, 2025

  JETT: Connecting Innovators with the Joint Chem Bio Enterprise

  Ricky Solorzano

• 

  October 3, 2025

  NIH Launches Nation’s First Dedicated Organoid Development Center

  Ricky Solorzano

• 

  September 25, 2025

  MIT and Polimi Develop Low-Cost AI Monitoring System to Improve 3D Bioprinting of Engineered Tissues

  Ricky Solorzano